2011 谘询委员会 |
||||
 |
 |
 |
 |
 |
| Debra Bingham Partner, VALEO PARTNERS |
Steven Dinh VP & Chief Scientific Officer, NOVEN PHARMACEUTICALS |
Peter Hoffmann, PhD Vice President, New Technology Development, GENZYME |
Peter B. Kramer Former Executive Director, Technology Transactions, Strategic Transactions Group, BRISTOL-MYERS SQUIBB PHARMACEUTICALS |
David Monteith, PhD Senior Director, Drug Delivery & Life Cycle Development, SCHERING-PLOUGH |
 |
 |
 |
 |
 |
| Bob Nissen President, NISSEN CONSULTING |
Jonathan Rigby VP, Business Development, ZOGENIX, INC. |
Vik Seoni Vice President & Head of Business Development, ELAN DRUG TECHNOLOGIES |
Lee Shorter Open Innovation Team, R&D, GLAXOSMITHKLINE |
Ralph A. Vitaro Publisher/President, Drug Delivery Technology, SPECIALTY PHARMA |